Pure Global

Ancillary study for the "phase III Study of adjuvant chemotherapy for the patients resected pathological stage I (T1>2cm) non-small cell lung cancer": Evaluation of long-term prognosis after resection for early-stage non-small cell lung cancer (JCOG0707A1) - Trial UMIN000048902

Access comprehensive clinical trial information for UMIN000048902 through Pure Global AI's free database. This Not Applicable trial is sponsored by Japan Clinical Oncology Group (JCOG) and is currently Recruitment Completed. The study focuses on Non-small cell lung cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000048902
Not Applicable
Recruitment Completed
Trial Details
University Hospital Medical Information Network โ€ข UMIN000048902
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Ancillary study for the "phase III Study of adjuvant chemotherapy for the patients resected pathological stage I (T1>2cm) non-small cell lung cancer": Evaluation of long-term prognosis after resection for early-stage non-small cell lung cancer (JCOG0707A1)
Evaluation of long-term prognosis after resection for early-stage non-small cell lung cancer (JCOG0707A1)

Study Focus

Observational

Sponsor & Location

Japan Clinical Oncology Group (JCOG)

Japan

Timeline & Enrollment

Not Applicable

Jun 03, 2022

N/A

ICD-10 Classifications

Secondary malignant neoplasm of lung
Malignant neoplasm: Lower lobe, bronchus or lung
Malignant neoplasm: Middle lobe, bronchus or lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm of bronchus and lung

Data Source

University Hospital Medical Information Network

UMIN000048902

Non-Device Trial